178 related articles for article (PubMed ID: 31635558)
1. Risk factors of infection-associated mortality in children with lupus nephritis in under-resourced areas.
Rianthavorn P; Prurapark P
Lupus; 2019 Dec; 28(14):1727-1734. PubMed ID: 31635558
[TBL] [Abstract][Full Text] [Related]
2. Infection in children with lupus nephritis receiving pulse and oral cyclophosphamide therapy.
Opastirakul S; Chartapisak W
Pediatr Nephrol; 2005 Dec; 20(12):1750-5. PubMed ID: 16133037
[TBL] [Abstract][Full Text] [Related]
3. Repeated pulses of methyl-prednisolone with reduced doses of prednisone improve the outcome of class III, IV and V lupus nephritis: An observational comparative study of the Lupus-Cruces and lupus-Bordeaux cohorts.
Ruiz-Irastorza G; Ugarte A; Saint-Pastou Terrier C; Lazaro E; Iza A; Couzi L; Saenz R; Richez C; Porta S; Blanco P
Autoimmun Rev; 2017 Aug; 16(8):826-832. PubMed ID: 28564619
[TBL] [Abstract][Full Text] [Related]
4. Fatal infection in children with lupus nephritis treated with intravenous cyclophosphamide.
Laoprasopwattana K; Dissaneewate P; Vachvanichsanong P
Pediatr Nephrol; 2009 Jul; 24(7):1337-43. PubMed ID: 19280226
[TBL] [Abstract][Full Text] [Related]
5. A retrospective study of catastrophic invasive fungal infections in patients with systemic lupus erythematosus from southern Taiwan.
Weng CT; Lee NY; Liu MF; Weng MY; Wu AB; Chang TW; Lin TS; Wang JY; Chang HY; Wang CR
Lupus; 2010 Sep; 19(10):1204-9. PubMed ID: 20515999
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and risk factors of herpes zoster infection in patients with biopsy proven lupus nephritis undergoing immunosuppressive therapies.
Mok CC; Tse SM; Chan KL; Ho LY
Lupus; 2020 Jul; 29(8):836-844. PubMed ID: 32408851
[TBL] [Abstract][Full Text] [Related]
7. Factors predictive of long-term mortality in lupus nephritis: a multicenter retrospective study of a Japanese cohort.
Ichinose K; Kitamura M; Sato S; Fujikawa K; Horai Y; Matsuoka N; Tsuboi M; Nonaka F; Shimizu T; Fukui S; Umeda M; Koga T; Kawashiri S; Iwamoto N; Tamai M; Nakamura H; Origuchi T; Nishino T; Kawakami A
Lupus; 2019 Mar; 28(3):295-303. PubMed ID: 30700214
[TBL] [Abstract][Full Text] [Related]
8. Clinical predictors of recovery and complications in the management of recent-onset renal failure in lupus nephritis: a Chinese experience.
Liang L; Yang X; Xu H; Zhan Z; Ye Y; Yu X; Chen W
J Rheumatol; 2004 Apr; 31(4):701-6. PubMed ID: 15088294
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of multitarget therapy with cyclophosphamide and tacrolimus for lupus nephritis: a prospective, single-arm, single-centre, open label pilot study in Japan.
Sakai R; Kurasawa T; Nishi E; Kondo T; Okada Y; Shibata A; Nishimura K; Chino K; Okuyama A; Takei H; Nagasawa H; Amano K
Lupus; 2018 Feb; 27(2):273-282. PubMed ID: 28683654
[TBL] [Abstract][Full Text] [Related]
10. Sequential therapy for diffuse proliferative and membranous lupus nephritis: cyclophosphamide and prednisolone followed by azathioprine and prednisolone.
Chan TM; Li FK; Wong RW; Wong KL; Chan KW; Cheng IK
Nephron; 1995; 71(3):321-7. PubMed ID: 8569982
[TBL] [Abstract][Full Text] [Related]
11. Induction therapy with low-dose intravenous cyclophosphamide, oral mizoribine, and steroids for severe lupus nephritis in children.
Fujinaga S; Kaneko K; Ohtomo Y; Murakami H; Takada M; Akashi S; Hira M; Yamashiro Y
Pediatr Nephrol; 2005 Oct; 20(10):1500-3. PubMed ID: 16021476
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children.
Tangnararatchakit K; Tapaneya-Olarn C; Tapaneya-Olarn W
J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S104-10. PubMed ID: 10730528
[TBL] [Abstract][Full Text] [Related]
13. Invasive fungal infections in Argentine patients with systemic lupus erythematosus.
Vinicki JP; Catalan Pellet S; Pappalardo C; Cruzat VC; Spinetto MA; Dubinsky D; Tiraboschi IN; Laborde HA; Nasswetter G
Lupus; 2013 Aug; 22(9):892-8. PubMed ID: 23861029
[TBL] [Abstract][Full Text] [Related]
14. Retrospective analysis of the renal outcome of pediatric lupus nephritis.
Wang LC; Yang YH; Lu MY; Chiang BL
Clin Rheumatol; 2004 Aug; 23(4):318-23. PubMed ID: 15293092
[TBL] [Abstract][Full Text] [Related]
15. Childhood lupus nephritis in a developing country-24 years' single-center experience from North India.
Singh S; Abujam B; Gupta A; Suri D; Rawat A; Saikia B; Minz RW; Joshi K; Nada R
Lupus; 2015 May; 24(6):641-7. PubMed ID: 25712249
[TBL] [Abstract][Full Text] [Related]
16. Lupus nephritis in children: a longitudinal study of prognostic factors and therapy.
Baqi N; Moazami S; Singh A; Ahmad H; Balachandra S; Tejani A
J Am Soc Nephrol; 1996 Jun; 7(6):924-9. PubMed ID: 8793802
[TBL] [Abstract][Full Text] [Related]
17. Outcome of lupus nephritis in childhood onset SLE in North and Central India: single-centre experience over 25 years.
Srivastava P; Abujam B; Misra R; Lawrence A; Agarwal V; Aggarwal A
Lupus; 2016 Apr; 25(5):547-57. PubMed ID: 26637291
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive therapy in lupus nephritis.
D'Cruz D; Cuadrado MJ; Mujic F; Tungekar MF; Taub N; Lloyd M; Khamashta MA; Hughes GR
Clin Exp Rheumatol; 1997; 15(3):275-82. PubMed ID: 9177922
[TBL] [Abstract][Full Text] [Related]
19. Effect of different hepatitis B infection status on the prognosis of active lupus nephritis treated with immunosuppression: a retrospective analysis of 177 patients.
Fang J; Li W; Tan M; Peng X; Tan Z; Wang W
Int J Rheum Dis; 2018 May; 21(5):1060-1067. PubMed ID: 29878614
[TBL] [Abstract][Full Text] [Related]
20. Infections in newly diagnosed Spanish patients with systemic lupus erythematosus: data from the RELES cohort.
González-Echavarri C; Capdevila O; Espinosa G; Suárez S; Marín-Ballvé A; González-León R; Rodríguez-Carballeira M; Fonseca-Aizpuru E; Pinilla B; Pallarés L; Ruiz-Irastorza G;
Lupus; 2018 Dec; 27(14):2253-2261. PubMed ID: 30451641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
